The stock of China SXT Pharmaceuticals Inc (SXTC) has gone up by 37.44% for the week, with a 8.59% rise in the past month and a -39.74% drop in the past quarter. The volatility ratio for the week is 18.86%, and the volatility levels for the past 30 days are 13.82% for SXTC. The simple moving average for the past 20 days is 13.23% for SXTC’s stock, with a -51.27% simple moving average for the past 200 days.
Is It Worth Investing in China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Right Now?
China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has a price-to-earnings ratio that is above its average at 0.20x. The stock has a 36-month beta value of 1.09.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SXTC is 3.43M, and at present, short sellers hold a 7.64% of that float. On December 31, 2024, the average trading volume of SXTC was 940.18K shares.
SXTC) stock’s latest price update
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has jumped by 5.22 compared to previous close of 0.42. Despite this, the company has seen a gain of 37.44% in its stock price over the last five trading days. globenewswire.com reported 2024-10-07 that Jiangsu, China, Oct. 07, 2024 (GLOBE NEWSWIRE) — China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC) announced today that on October 3, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).
SXTC Trading at -2.58% from the 50-Day Moving Average
After a stumble in the market that brought SXTC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -93.12% of loss for the given period.
Volatility was left at 13.82%, however, over the last 30 days, the volatility rate increased by 18.86%, as shares surge +9.92% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -32.65% lower at present.
During the last 5 trading sessions, SXTC rose by +37.44%, which changed the moving average for the period of 200-days by -75.01% in comparison to the 20-day moving average, which settled at $0.3884. In addition, China SXT Pharmaceuticals Inc saw -88.92% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SXTC
Current profitability levels for the company are sitting at:
- -1.3 for the present operating margin
- 0.23 for the gross margin
The net margin for China SXT Pharmaceuticals Inc stands at -1.61. The total capital return value is set at -0.18. Equity return is now at value -21.65, with -11.76 for asset returns.
Based on China SXT Pharmaceuticals Inc (SXTC), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -0.68.
Currently, EBITDA for the company is -2.35 million with net debt to EBITDA at -3.45. When we switch over and look at the enterprise to sales, we see a ratio of -4.09. The receivables turnover for the company is 1.47for trailing twelve months and the total asset turnover is 0.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.60.
Conclusion
To sum up, China SXT Pharmaceuticals Inc (SXTC) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
